Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Jiangsu Carephar Pharmaceutical Co., Ltd.

Clinical trials sponsored by Jiangsu Carephar Pharmaceutical Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New oral pill H021 aims to tame Crohn's Flare-Ups Results expected Oct 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

New oral pill H021 aims to tame Crohn's Flare-Ups

Disease control Not yet recruiting

This phase 2 trial tests whether an experimental oral tablet called H021 can help people with moderate to severe Crohn's disease. Participants receive either a low or high dose of H021 or a placebo for 12 weeks, with an option to continue treatment. The study measures symptom imp…

Phase 2 • Sponsor: Jiangsu Carephar Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jul 02, 2026 00:00 UTC